NLE Neurosensory Nursing — Cerebrovascular Disorders and Increased Intracranial PressureSummary

A stroke is a sudden loss of brain function caused by disrupted cerebral blood flow, resulting in neuronal death within minutes. Strokes are classified as ischemic (80–85% of cases) when blood flow is blocked by a thrombus (clot forming in situ) or embolus (clot traveling from elsewhere), or hemorrhagic (15–20% of cases) when a cerebral vessel ruptures. The distinction is critical because ischemic stroke is treated with thrombolytics (clot busters), while hemorrhagic stroke is worsened by these drugs. An emergent non-contrast CT scan is the first diagnostic priority to rule out bleeding before any thrombolytic therapy is given.

Ischemic stroke occurs when a blood clot blocks a cerebral artery, cutting off oxygen supply to brain tissue. The blocked area dies (infarct), but surrounding tissue enters a state of metabolic crisis called the penumbra—potentially salvageable if perfusion is restored. The intravenous thrombolytic alteplase (tissue plasminogen activator, or tPA) dissolves the clot and restores blood flow. The critical treatment window is within approximately 3 hours of symptom onset (extended to 4.5 hours in eligible patients without contraindications). Establishing the exact time the patient was 'last known well' is essential because tPA cannot be given if onset is unknown beyond specialized imaging-guided protocols. Absolute contraindications include any evidence of intracranial hemorrhage on CT, active internal bleeding, recent intracranial surgery or head trauma, history of intracranial hemorrhage, and uncontrolled severe hypertension (must lower BP below approximately 185/110 mmHg before giving tPA). The dose is 0.9 mg/kg body weight (maximum 90 mg), with 10% given as initial bolus over 1 minute and the remainder infused over 60 minutes.

Hemorrhagic stroke results from rupture of a cerebral blood vessel, most commonly due to uncontrolled hypertension or rupture of a cerebral aneurysm or arteriovenous malformation (AVM). Bleeding both destroys tissue directly and raises intracranial pressure, compressing surrounding brain. A ruptured cerebral aneurysm, most commonly located in the anterior circle of Willis, presents as subarachnoid hemorrhage (SAH)—bleeding into the subarachnoid space. The classic presentation is a sudden 'worst headache of my life,' neck stiffness (meningeal irritation from blood), photophobia, and often rapid neurologic decline. Diagnosis is by non-contrast CT (blood appears hyperdense/white), and if CT is negative but clinical suspicion remains, lumbar puncture shows xanthochromia (yellow discoloration from hemoglobin breakdown). Hemorrhagic strokes are absolutely contraindicated for thrombolytic therapy and anticoagulation, and management focuses on preventing rebleeding (surgery or endovascular coiling to repair the aneurysm) and controlling ICP.

A TIA is a brief episode of neurologic dysfunction caused by temporary cerebral ischemia, with symptoms that resolve completely—typically within 1 hour but by definition within 24 hours—without permanent infarction. The deficits are identical to stroke (weakness, speech difficulty, vision loss) but temporary. A TIA has no abnormality on brain imaging (by definition, if there is infarction, it is a stroke, not a TIA). The critical concept is that a TIA is a major warning sign: a significant proportion of patients progress to a full stroke, many within days (approximately 10% within 3 months). Therefore, TIA demands urgent workup including imaging, cardiac evaluation, carotid imaging, and blood glucose, and immediate initiation of secondary prevention (antiplatelet therapy like aspirin, control of hypertension and diabetes, smoking cessation, lipid management).

Stroke deficits depend on which artery is blocked and which hemisphere is affected. Neurologic deficits are contralateral—that is, a left-hemisphere stroke causes right-sided weakness and often language problems (aphasia), while a right-hemisphere stroke causes left-sided weakness and often spatial neglect and impulsiveness. Common manifestations include hemiparesis or hemiplegia (weakness or paralysis on one side of the body), aphasia (expressive if in Broca's area, receptive if in Wernicke's area, or global), dysphagia (swallowing difficulty—a major aspiration risk), hemianopia (loss of half the visual field), and unilateral neglect (seen in right-hemisphere strokes, where the patient ignores the left side of space). The FAST mnemonic is a public health tool: Face drooping, Arm weakness, Speech difficulty, Time to call for emergency help. If any FAST sign is present, emergency services must be activated immediately because 'time is brain.'

The skull is a rigid compartment containing three relatively incompressible components: the brain (~80%), cerebrospinal fluid (~10%), and blood (~10%). The Monro-Kellie doctrine states that when one component increases (e.g., from brain edema, hemorrhage, tumor, or hydrocephalus), another must decrease to maintain constant total volume and pressure. Once this compensation is exhausted, any further increase in volume causes exponential increases in pressure. Normal ICP is 5–15 mmHg; sustained pressures above 20 mmHg require treatment, and pressures above 40 mmHg often cause irreversible brain damage. Uncontrolled ICP compresses and shifts brain tissue, leading to herniation and death. Increased ICP can result from vasogenic edema (fluid around tumor cells or infection), cytotoxic edema (fluid inside brain cells from ischemia or trauma), or increased blood volume (from cerebral vasodilation due to hypoxia, hypercapnia, or fever).

Cushing's triad is a classically taught set of three findings associated with increased ICP: (1) a rising systolic blood pressure with a widening pulse pressure (the difference between systolic and diastolic), (2) bradycardia (slow heart rate), and (3) irregular respirations (often described as Cheyne-Stokes or ataxic). However, and this is critical for the NLE, Cushing's triad is a LATE sign—it indicates that the brainstem is being compressed and herniation is imminent. The EARLIEST sign of increased ICP, and the one nurses should monitor most vigilantly, is a DECREASING LEVEL OF CONSCIOUSNESS (LOC). This may be subtle at first—the patient becomes less responsive, drowsy, or confused. Progression to coma signifies advanced ICP elevation. Other early signs include headache (often worse on waking), projectile vomiting (without nausea), papilledema (swelling of the optic disk), and pupillary changes—classically a unilateral fixed, dilated pupil from compression of the oculomotor nerve (cranial nerve III). Abnormal posturing (decorticate, then decerebrate) is a late, ominous sign.

ICP management focuses on preventing secondary injury and maintaining cerebral perfusion pressure (CPP = Mean Arterial Pressure minus ICP; target CPP is roughly 60–70 mmHg). Key nursing interventions include: (1) Maintaining a patent airway and adequate oxygenation—hypoxia and hypercapnia cause cerebral vasodilation and worsen ICP. Avoid suctioning longer than 10–15 seconds, oxygenate the patient before suctioning, and monitor oxygen saturation closely. (2) Elevating the head of the bed to 30 degrees and keeping the head and neck in neutral, midline alignment—this promotes venous drainage from the cranium, reducing venous blood volume and ICP. Avoid extreme flexion of the hips (which increases intra-abdominal pressure and impairs venous return) and avoid turning the head sharply. (3) Preventing activities that raise intrathoracic or intra-abdominal pressure—avoid Valsalva maneuvers, straining during bowel movements, coughing, and vigorous suctioning. Give stool softeners to prevent constipation-induced straining, and avoid urinary catheters if possible (insertion can trigger Valsalva). (4) Clustering nursing care and allowing frequent rest periods to prevent repeated stimulation that raises ICP. (5) Maintaining a calm, quiet environment—excessive noise, bright lights, and stimulation increase cerebral metabolism and ICP. Keep the room temperature slightly cool because fever raises cerebral metabolic rate and ICP. (6) Monitoring for and managing fever aggressively with antipyretics, tepid baths, or cooling devices. (7) Avoiding hypotension because it worsens cerebral perfusion. (8) Preventing seizures with prophylactic antiseizure medications if seizure risk is high.

Two primary pharmacologic agents manage cerebral edema: (1) Mannitol—an osmotic diuretic that works by pulling fluid from brain tissue (which has a lower osmolality) into the vasculature, thereby reducing cerebral edema. Typical dose is 0.25–1 g/kg IV bolus, infused over 15–30 minutes. It should be administered through an in-line filter (because it can crystallize) and the IV line must be patent (extravasation causes tissue necrosis). Nursing considerations include monitoring serum osmolality (keep below approximately 320 mOsm/kg to avoid rebound edema), monitoring hourly urine output (mannitol increases urine output; watch for dehydration), assessing electrolytes frequently (mannitol can cause hypokalemia and hypernatremia), and weighing the patient daily. Rebound edema can occur if the blood-brain barrier is disrupted or if mannitol is given repeatedly. (2) Hypertonic saline (e.g., 3% NaCl)—an alternative osmotic agent that also pulls water from edematous brain tissue and may have immunomodulatory benefits. Infuse through central line for concentrations >3%. (3) Corticosteroids, particularly dexamethasone, reduce vasogenic edema (fluid around tumor cells or infection) by stabilizing the blood-brain barrier. However, corticosteroids are NOT effective for cytotoxic edema (swelling of brain cells from ischemia or head trauma). Dexamethasone is used in brain tumors and abscesses but not routinely in ischemic stroke or closed head injury.

Head injuries range from concussion (brief LOC or confusion without structural damage) to severe traumatic brain injury. Three specific conditions demand rapid recognition: (1) Epidural hematoma—bleeding between the skull and the outer dura mater, usually from the middle meningeal artery (an arterial source). The classic presentation includes an immediate LOC, then a deceptive 'lucid interval' when the patient appears to recover, followed by rapid, catastrophic deterioration (coma, fixed dilated pupils, death) as the hematoma expands. This is a surgical emergency requiring immediate craniotomy to stop bleeding. Nurses must recognize that a patient who 'woke up' after a head injury is not safe to discharge; the lucid interval is a trap. (2) Subdural hematoma—venous bleeding beneath the dura mater, often between the dura and brain surface. Acute subdural occurs within 72 hours of injury and presents similarly to epidural but without the lucid interval. Chronic subdural develops slowly over weeks, especially in older adults and those on anticoagulants, and may present with vague cognitive decline, falls, or subtle neurologic change. (3) Basilar skull fracture—fracture at the base of the skull, often involving the cribriform plate or temporal bone. Classic signs are CSF leaking from the nose (rhinorrhea) or ear (otorrhea—described as 'clear drainage from the ear'), 'raccoon eyes' (bilateral periorbital ecchymosis), and 'Battle's sign' (ecchymosis over the mastoid process). Nurses must test suspicious drainage for CSF using the 'halo sign' (CSF, being less protein-dense, rings around blood on filter paper) or glucose testing (CSF contains glucose; normal drainage does not). CRITICAL: Never pack the nose or ears, avoid nasogastric tube insertion (risk of intracranial placement) and nasal suctioning; some centers place an orogastric tube instead.

Brain tumors, whether primary (gliomas, meningiomas) or metastatic, are dangerous not because of histology but because they raise ICP within the rigid skull. Even benign tumors cause mass effect, compression, and edema. Manifestations depend on location and include headache (often waking the patient, suggesting raised ICP), seizures (from abnormal electrical activity), focal neurologic deficits (weakness, sensory loss, vision loss), personality changes, memory problems, and signs of increased ICP. Diagnosis is by MRI with gadolinium contrast (MRI better shows soft tissue; contrast helps visualize tumor margins and edema). Biopsy provides histologic diagnosis. Treatment includes surgical resection (craniotomy), radiation therapy, and chemotherapy; corticosteroids (e.g., dexamethasone) reduce peritumoral vasogenic edema and are particularly useful preoperatively. Postoperative craniotomy care includes strict neurologic checks (every 1 hour initially, then every 4 hours if stable) to detect increasing ICP or new focal deficits suggesting hemorrhage or edema. Positioning depends on the surgical approach: if the tumor was in the frontal or parietal lobe, the patient is usually kept on the non-operative side to prevent pressure on the incision; positioning instructions vary. ICP precautions are continued (head elevation, midline alignment, quiet environment). Dressings are observed for CSF leakage (if present, the dressing is reinforced and the surgeon notified—CSF leakage increases infection risk). Pain management is important but must be balanced against the need for frequent neuro checks.

Stroke survivors face multiple complications: (1) Aspiration pneumonia—from dysphagia (swallowing difficulty), the most common stroke complication. Nurses must screen for dysphagia before allowing any oral intake, typically using a formal swallow screen. Diet is modified based on swallowing ability (thickened liquids, pureed foods) as prescribed by speech therapy. (2) Deep vein thrombosis and pulmonary embolism—from immobility. Prophylactic measures include early mobilization, sequential compression devices, or anticoagulant prophylaxis. (3) Contractures and pressure injuries—from prolonged immobility. Range-of-motion exercises, proper positioning, and frequent turning are essential. (4) Neurogenic bladder—from loss of control, requiring bladder management strategies (intermittent catheterization, timed voids, protective garments). For long-term outcomes, stroke survivors require rehabilitation to regain function, cognitive-behavioral support for depression and emotional changes, and consistent secondary prevention to prevent recurrent stroke. Secondary prevention includes blood pressure control (target usually <140/90 mmHg, though this may be individualized), antiplatelet therapy (aspirin, clopidogrel) or anticoagulation if atrial fibrillation or cardioembolic source is present, statin therapy (even if cholesterol is normal, for plaque stabilization), diabetes management, smoking cessation, and lifestyle modification (diet low in sodium and saturated fat, regular exercise, weight loss if obese). Caregiver education is crucial: family must recognize FAST warning signs, understand medication adherence, know how to approach the patient from the unaffected side (to help with unilateral neglect or hemianopia), and understand the patient's emotional needs and changed personality.

The non-contrast CT scan result determines the entire treatment pathway. If ischemic, the patient is candidate for tPA (within window) or aspirin and supportive care. If hemorrhagic, tPA and anticoagulants are contraindicated; instead, the focus shifts to surgery/endovascular repair (for aneurysm), ICP management, and hemostasis. This relationship underscores why imaging is the critical first step—it branches all subsequent interventions.

The tPA window (3–4.5 hours) is based on the concept that the penumbra (tissue at risk of infarction) is salvageable if perfusion is restored quickly, but the window closes as the penumbra progressively dies. Mechanical thrombectomy extends this window in large-vessel occlusions. The relationship emphasizes that every minute counts—delays in recognition, transport, imaging, or treatment reduce the probability of successful reperfusion and good outcome. Nurses facilitating rapid response directly impact patient prognosis.

Increased ICP begins with subtle signs (early: decreasing LOC, headache, vomiting; intermediate: pupillary changes, abnormal posturing; late: Cushing's triad). If unmanaged, progressive ICP leads to brain herniation and death. This relationship explains why early recognition of decreasing LOC (not waiting for Cushing's triad) and immediate intervention are critical—once herniation begins, reversal becomes difficult or impossible. The relationship is one of urgency and prevention.

Mannitol works because the Monro-Kellie doctrine explains that reducing brain volume (by pulling fluid out) lowers ICP. Corticosteroids reduce vasogenic edema by stabilizing the blood-brain barrier, but they don't help cytotoxic edema; thus, they're used for tumors (vasogenic) but not ischemic stroke (cytotoxic). This relationship shows that understanding pathophysiology guides rational drug selection and explains why one drug works in one condition but not another.

TIA and stroke exist on a continuum of cerebral ischemia: both result from temporary or permanent loss of blood flow. The difference is temporal and radiologic—TIA resolves within 24 hours without infarction, while stroke leaves permanent tissue damage. This relationship explains why TIA is a warning sign: the underlying vascular disease (atherosclerosis, atrial fibrillation, carotid stenosis) that caused temporary ischemia is still present and poses ongoing risk. The urgency of TIA evaluation and secondary prevention mirrors stroke prevention.

Epidural hematoma (arterial, rapid accumulation) elevates ICP acutely and catastrophically, warranting emergency surgery. Subdural hematoma (venous, slower accumulation) may develop gradually, especially in elderly and anticoagulated patients, presenting with subtle changes. Both increase ICP, but the time course differs, affecting urgency of intervention. This relationship shows how anatomy (arterial vs. venous source) and patient factors (age, anticoagulation) shape clinical presentation and required speed of response.

Primary prevention (controlling hypertension, diabetes, atrial fibrillation in at-risk individuals) reduces first stroke risk. Recognition (FAST mnemonic) ensures rapid response when stroke occurs. Acute treatment (tPA, supportive care) minimizes damage. Secondary prevention (antiplatelet therapy, BP control, statins, smoking cessation, rehabilitation) reduces recurrent stroke risk. This continuum shows that stroke care is not just an acute hospital event but a lifelong management challenge, with nurses playing roles at each stage.

In acute increased ICP (e.g., post-craniotomy), neuro checks are done every 1 hour to detect rapid changes. As ICP stabilizes, checks may be spaced to every 4 hours. If new deterioration occurs, checks revert to hourly. This relationship shows that the nursing assessment schedule reflects the dynamic nature of ICP—frequent checks early detect problems early; less frequent checks later conserve resources when the patient is stable. Responsiveness of neuro checks to patient condition is a sign of nursing judgment.